The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

about

The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

Item

http://www.wikidata.org/entity/Q39456177

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The development, commercializa ...... resin and glass microspheres.

@en

The development, commercializa ...... resin and glass microspheres.

@nl

type

Item

label

The development, commercializa ...... resin and glass microspheres.

@en

The development, commercializa ...... resin and glass microspheres.

@nl

prefLabel

The development, commercializa ...... resin and glass microspheres.

@en

The development, commercializa ...... resin and glass microspheres.

@nl

P1476

The development, commercializa ...... resin and glass microspheres.

@en

P2093

David M Liu

http://www.w3.org/2001/XMLSchema#string

Douglas M Coldwell

http://www.w3.org/2001/XMLSchema#string

Joseph F Zikria

http://www.w3.org/2001/XMLSchema#string

Mark A Westcott

http://www.w3.org/2001/XMLSchema#string

P2860

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable li

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.

Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.

RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES.

Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes

Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.

The blood supply of neoplasms in the liver.

Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.

P304

351-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADRO.2016.08.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740906

http://www.w3.org/2001/XMLSchema#string

P921

commercialization

P932

5514171

http://www.w3.org/2001/XMLSchema#string